In 2024, ViarLive OÜ had revenue of 42.7 thousand EUR and profit of 5.2 thousand EUR. Beneficial owners: Anton Perkin, Ghennadi Ganebnîi.
| year | 2024Latest | 2023 |
|---|---|---|
Revenue | 42,7k € +31.9% | 32,4k € |
Profit | 5,2k € +106.0% | -86,6k € |
Assets | - | - |
Liabilities | - | - |
Equity | 21,9k € +34.0% | 16,4k € |
Employees | - | - |
Overall rating | A89/100 |
Financial health | 100/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 85/100 |
| Overall risk | Low |
No risk flags | |
Possible tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | - | |||
| - | Procurator | - | |||
| - | Board member | - |
ViarLive OÜ is located at Harju maakond, Tallinn, Kesklinna linnaosa, A. Lauteri tn 3, 10114.
In 2024, ViarLive OÜ had revenue of 42 742 EUR and profit of 5196 EUR. Compared to previous year, revenue increased by 31.9%. View full financial report →
The beneficial owners of ViarLive OÜ are Anton Perkin and Ghennadi Ganebnîi. View ownership details →
No, ViarLive OÜ does not have an active VAT number and is not registered as a VAT payer.
ViarLive OÜ was founded on March 20, 2023. The company has been operating for 3 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 3 years | 4121 - 4125 | 21% | |
Net revenue | 42 742,00 € | 2758 - 2762 | 47% | |
Profit | 5196,00 € | 2554 - 2558 | 51% | |
Equity | 21 923,00 € | 2786 - 2790 | 43% | |
Liquidity | 4.94 | - | 90% | |
Profitability | 12.2% | - | 25% | |
Registered capital | 3052,78 € | - | 50% |
Annual financial report for 2024.
Annual financial report for 2023.
Registered in the Estonian business register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| Anton Perkin | - | 40.95% | |
| Ghennadi Ganebnîi | - | 40.95% | |
| Nicolai Opopol | - | 10.24% | |
| Usaldusfond Wise Guys Ventures Fond 2 | - | 7.87% | |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Anton Perkin | MD | - | |
| Ghennadi Ganebnîi | MD | - |